Inflazome

Last updated: July 09, 2024

Founder Matthew Cooper
Founder Matthew Cooper
Ireland | Funding: $63.8M (+)

Website: http://inflazome.com

Inflazome develops targeted therapies for inflammatory diseases. Inflammasomes generate signals that cause immune cells to fight infections.